PUK14 A COST-UTILITY ANALYSIS IN A UK SETTING OF CINACALCET FOR SECONDARY HYPERPARATHYROIDISM IN END STAGE RENAL DISEASE
Autor: | Mealing, SJ, Garside, R, Pitt, M, Anderson, R, D'Sousa, R, Stein, K |
---|---|
Zdroj: | In Value in Health 2006 9(6):A388-A389 |
Databáze: | ScienceDirect |
Externí odkaz: |